×
About 330 results

ALLMedicine™ Alopecia Totalis Center

Research & Reviews  92 results

Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhib...
https://doi.org/10.1016/j.jaut.2022.102926
Journal of Autoimmunity; Paggioli I, Moss J

Nov 7th, 2022 - Alopecia Areata (AA) is a T-cell mediated autoimmune attack on hair follicles resulting in rapidly developing areas of hair loss involving the scalp and beard that can progress to total scalp hair loss (alopecia totalis) and loss of eyebrows, eyel...

Clinical Application of Stem Cell Educator Therapy in Alopecia Areata
https://clinicaltrials.gov/ct2/show/NCT04011748

Sep 22nd, 2022 - Alopecia areata (AA) is a common autoimmune disease that results in loss of body hair in varying degrees. The condition is estimated to affect more than 6.5 million people in the United States alone (naaf.org), with a worldwide prevalence of 0.1% ...

Retrospective analysis of methylprednisolone treatment alone and in combination with me...
https://doi.org/10.1111/dth.15776
Dermatologic Therapy; Altun E, Yaylı S et. al.

Aug 21st, 2022 - Alopecia areata (AA) is a chronic autoimmune disorder that primarily affects the hair follicle. Systemic corticosteroids and methotrexate (MTX) are among the therapeutic options in severe cases. This study aimed to show whether the combination the...

A Study of KL130008 in Adults With Severe Alopecia Areata
https://clinicaltrials.gov/ct2/show/NCT05496426

Aug 11th, 2022 - This is a multi-center Phase 2 study to evaluate the safety and effectiveness of an investigational drug in adults (≥18 years and ≤65 years) who have 50% or greater scalp hair loss, including alopecia totalis (AT) and alopecia universalis (AU).

Unique Treatment for Alopecia Areata Combining Epinephrine With an Intralesional Steroid
https://www.mdedge.com/dermatology/article/256923/hair-nails/unique-treatment-alopecia-areata-combining-epinephrine
Eugeniu Stratulat, MD, Terri Shih, BS et. al.

Aug 9th, 2022 - Alopecia areata (AA) is an autoimmune disorder characterized by transient hair loss with preservation of the hair follicle (HF). The lifetime incidence risk of AA is approximately 2%,1 with a mean age of onset of 25 to 36 years and with no clinica.

see more →

Clinicaltrials.gov  15 results

Clinical Application of Stem Cell Educator Therapy in Alopecia Areata
https://clinicaltrials.gov/ct2/show/NCT04011748

Sep 22nd, 2022 - Alopecia areata (AA) is a common autoimmune disease that results in loss of body hair in varying degrees. The condition is estimated to affect more than 6.5 million people in the United States alone (naaf.org), with a worldwide prevalence of 0.1% ...

A Study of KL130008 in Adults With Severe Alopecia Areata
https://clinicaltrials.gov/ct2/show/NCT05496426

Aug 11th, 2022 - This is a multi-center Phase 2 study to evaluate the safety and effectiveness of an investigational drug in adults (≥18 years and ≤65 years) who have 50% or greater scalp hair loss, including alopecia totalis (AT) and alopecia universalis (AU).

Clinical Trial to Evaluate the Efficacy of Fecal Microbiota Transplantation in Patients With Alopecia Areata
https://clinicaltrials.gov/ct2/show/NCT04238091

Mar 21st, 2022 - Alopecia areata (AA) is an autoimmune condition resulting in chronic and relapsing hair loss. AA patchy is associated with well-circumscribed patches of hair loss, commonly on the scalp or face, while alopecia totalis (AT) and alopecia universalis...

Fecal Transplant for Alopecia Areata
https://clinicaltrials.gov/ct2/show/NCT04833179

Apr 6th, 2021 - Alopecia areata (AA) is a common autoimmune disease that triggers non scarring hair loss in different severities. Usually the hair loss will be contained to the scalp and / or beard, but in some cases, there will be total hair loss from the entire...

A Study of Secukinumab for the Treatment of Alopecia Areata
https://clinicaltrials.gov/ct2/show/NCT02599129

Mar 11th, 2021 - Alopecia areata is a medical condition, in which the hair falls out in patches. The hair can fall out on the scalp or elsewhere on the face and body. Alopecia areata is an autoimmune skin disease, which means that the immune system is recognizing ...

see more →

News  25 results

Unique Treatment for Alopecia Areata Combining Epinephrine With an Intralesional Steroid
https://www.mdedge.com/dermatology/article/256923/hair-nails/unique-treatment-alopecia-areata-combining-epinephrine
Eugeniu Stratulat, MD, Terri Shih, BS et. al.

Aug 9th, 2022 - Alopecia areata (AA) is an autoimmune disorder characterized by transient hair loss with preservation of the hair follicle (HF). The lifetime incidence risk of AA is approximately 2%,1 with a mean age of onset of 25 to 36 years and with no clinica.

Focal hair loss
https://www.mdedge.com/familymedicine/article/254363/dermatology/focal-hair-loss
MDedge Family Medicine;

May 5th, 2022 - The findings of smooth, round alopecia occurring rapidly without associated scarring, pain, or itching, is consistent with the diagnosis of alopecia areata. Alopecia areata is a common autoimmune disease caused by T lymphocytes targeting hair foll.

Review looks at natural course of alopecia areata in young children
https://www.mdedge.com/dermatology/article/208895/pediatrics/review-looks-natural-course-alopecia-areata-young-children
Jake Remaly

Sep 26th, 2019 - Most children who develop alopecia areata before age 4 years have mild disease with less than 50% hair loss, and present between ages 2 and 4, according to a retrospective chart review of 125 children. Almost 90% of the children presented between.

Another JAK Inhibitor Shows Promise for Alopecia Areata
https://www.medscape.com/viewarticle/910163

Mar 11th, 2019 - The Janus kinase (JAK) inhibitor CTP-543 (Concert Pharmaceuticals) is effective for the treatment of moderate to severe alopecia areata, according to interim results from a phase 2a randomized safety and efficacy study (NCT03137381). "We've identi...

The Case of the Disappearing Eyebrows
https://www.mdedge.com/clinicianreviews/article/195335/dermatology/case-disappearing-eyebrows/page/0/1?channel=203

Feb 28th, 2019 - DISCUSSION This case illustrates several variants of an extremely common condition: alopecia areata (AA), literally translated as “hair loss confined to a particular localized area or areas. ” Although AA is more common in adults, it often affects.

see more →